Please provide your email address to receive an email when new articles are posted on . Edward V. Loftus Jr. Though I see some interesting mirrors between pediatric and adult gastroenterology in the ...

Constipation in children can be caused by a range of problems including the use of certain medications, poor health or a lack of proper nutrition. A teenager who freezes when confronted with using the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Linzess, the first therapy for pediatric functional constipation in patients aged 6 to 17 ...

Credit: Shutterstock. Linzess is a guanylate cyclase-C agonist. The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the treatment of functional constipation (FC) in ...

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a leading global gastrointestinal healthcare company, will present findings during the 2023 North American Society for Pediatric ...

Credit: Getty Images. The application was supported by data from a phase 3 trial that included 330 patients 6 to 17 years of age with functional constipation. The Food and Drug Administration (FDA) ...

I received a question from one of our twitter followers about her daughter who was recently found to be constipated. She wanted some information on treating constipation. Do you know how common ...

A newly approved option for pediatric patients with functional constipation significantly increased the frequency of bowel movements and improved other burdensome symptoms as well, according to a ...

Rates of unnecessary abdominal X-rays decreased from 62% to 24% in children seen in the emergency department (ED) for constipation after implementation of a quality improvement intervention. The study ...

(RTTNews) - Ironwood Pharmaceuticals, Inc. (IRWD), Monday announced that the U.S. Food and Drug Administration has approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AbbVie, in collaboration with Ironwood ...